Life Science Newswire
  • Home
  • Pricing
  • Newsroom
  • COVID-19 Newsroom
  • About Us
Select Page

Senior appointments enhance Sygnature Discovery’s DMPK capabilities

by Life Science Newswire | Mar 21, 2019 | Biotechnology, Corporate, Finance & Investor, Drug Discovery & Development, Pharma

Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, has recruited four key individuals to boost its DMPK (drug metabolism and pharmacokinetics) capabilities. Dr Stuart Best, Dr Hayley Butler, Dr Daniel Weston and Dr...

Recent Posts

  • Indica Labs, Octo and Axle work with NIH to launch a global COVID-19 digital pathology repository
  • Nori Health offers free access to smart chatbot for people with Crohn’s and Colitis during the crisis
  • Mirror Biologics and Immunovative Therapies announce publication of the technical rationale for development of a universal anti-viral vaccine targeted to protect eldery adults from COVID-19 and any future novel virus outbreaks.
  • DefiniGEN launches tool for coronavirus-specific intestinal cell research
  • Digital Science reports that just 10% of global research output relates to the UN’s Sustainable Development Goals

Archives

  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
To give you the best possible experience, this website uses cookies and by continuing to browse you are giving consent to cookies being used. To find out more about how we use them please read our Privacy Policy. Find out more.